Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Analog of staurosporine.
Tretraeptide, binds cell surface integrins.
Phenyl hydrazide; neuronal oxidative stress inh...
NMDA NR1/NR2B antagonist.
GHB agonist, D2/3 antagonist.
Synthetic steroid hormone; AR and ER antagonist...
Binds to neurotoxin receptor site 2 on voltage-...
Natural anthraquinone derivative
Non-essential amino acid alcohol.
Carotene pigment found in red and green fruits ...
Juvenile insect hormone mimic.
Macrolide; protein translation inhibitor, mamma...
Statin; HMG-CoA reductase inhibitor.
TRPC5, NS4B, histamine H1 inhibitor.
Calpain I/II inhibitor.
Endogenous quaternary ammonium, required for fa...
Minor kavalactone originally found in Piper met...
Aromatase inhibitor.
NSAID; GABA-A potentiator, COX-1/2 inhibitor.
AMPK activator.